Surgery Partners Q2 Adj $0.21 Beats $0.20 Estimate, Sales $762.10M Beat $735.57M Estimate
Portfolio Pulse from Benzinga Newsdesk
Surgery Partners (NASDAQ:SGRY) reported Q2 earnings of $0.21 per share, beating the analyst estimate of $0.20. Sales were $762.10 million, surpassing the $735.57 million estimate. Despite the earnings beat, EPS decreased by 25% year-over-year.
August 06, 2024 | 11:36 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Surgery Partners (SGRY) reported Q2 earnings of $0.21 per share, beating the analyst estimate of $0.20. Sales were $762.10 million, surpassing the $735.57 million estimate. Despite the earnings beat, EPS decreased by 25% year-over-year.
The earnings and revenue beats are positive indicators for the stock in the short term. However, the year-over-year decrease in EPS may temper some of the enthusiasm. Overall, the positive earnings surprise and revenue growth are likely to have a favorable impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100